Main navigation
- Programs
- Subjects
- Universities
- Destinations
- Advice
This program provides comprehensive insight into the scientific foundations of oncology principles and practices, along with the process of developing, assessing, and applying new treatments. You'll acquire specialized expertise in cancer biology, pathology, pharmaceutical development, and research methodologies, equipping you with a strong foundation for clinical oncology practice. This MSc is also open to intercalating MBBS students. Additional details can be found here.
Led by specialists from Barts Cancer Institute—a key member of the Cancer Research UK City of London Centre, a globally renowned hub focused on cancer biotherapeutics
Engage with cutting-edge advancements in cancer treatment, including gene therapy
Flexible part-time study option to balance your education with professional or personal commitments
In-depth training in research methodologies and statistical analysis
A valuable career accelerator: Learn to design and implement innovative treatment approaches
**What You'll Study**
This MSc delivers a robust understanding of the scientific principles behind oncology. By completing the course, you will:
- Understand the development, evaluation, and implementation of new therapies
- Gain in-depth knowledge of cancer biology, pathology, research methods, and drug development
- Comprehend the ethical and regulatory frameworks governing clinical research
- Analyze the applications of radiotherapy, surgery, and imaging technologies in cancer treatment, assessing their risks and benefits in clinical contexts
- Identify and utilize appropriate research techniques to collect, document, and critically evaluate data
These skills will significantly enhance your career opportunities in cancer research.
You’ll also complete a three-month dissertation supervised by one of our research leaders. This may involve designing a simulated clinical trial to gain hands-on experience in cancer-related clinical research and drug development.
A 2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution.
Applicants with a 2:2 degree will be considered on an individual basis.
 
The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.
 
IELTS (Academic) minimum score 6.5 overall with 6.0 in each of Writing, Listening, Reading and Speaking.  TOEFL minimum score 92 overall with 21 in Writing, 19 in Reading, 18 in Listening and 21 in Speaking.